Demis Hassabis on AGI

About Demis Hassabis

Demis Hassabis, co-founder and CEO of Google DeepMind and 2024 Nobel laureate in Chemistry for AlphaFold, has continued to discuss the timeline for artificial general intelligence (AGI) and its potential applications. In multiple recent appearances, Hassabis stated that he believes AGI could arrive around 2030, describing the current period as the "foothills of the singularity." He has emphasized that key capabilities such as continual learning, long-term reasoning, and aspects of memory remain unsolved challenges. Hassabis has also discussed the importance of the "agentic era," where AI systems actively solve problems, as a path toward AGI. Hassabis has frequently highlighted the potential of AI to revolutionize drug discovery and medicine, stating that he believes AI could help cure every disease on Earth within a decade. He described a goal of reducing drug discovery times from an average of 10 years to months, weeks, or even days. Hassabis noted that Isomorphic Labs has test compounds in pre-clinical stage and that he views the first AI-designed drug reaching patients as a potential watershed moment. He has also expressed concern about public perception of AI, stating that the public is "right to be concerned" and that the technology is "dual purpose." Hassabis has called for international standards and cooperation on AI safety, and has advocated for the industry to demonstrate more unequivocal benefits of the technology, particularly in health and science.

Profile compiled from Demis Hassabis's verified public interviews and appearances. See all quotes & transcripts →